Results 351 to 353 of about 785,489 (353)
Some of the next articles are maybe not open access.
Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer.
Journal of Clinical Oncology, 2017Suresh S. Ramalingam +15 more
semanticscholar +1 more source
Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC
Nature Reviews Clinical Oncology, 2009Helena Linardou
exaly